NantHealth Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
225,570.00
7,232.00
157,673.00
62,010.00
18,305
Total Accounts Receivable
3,064.00
15,211.00
12,366.00
12,076.00
16,293
Inventories
2,946.00
2,146.00
1,685.00
839.00
496
Other Current Assets
1,638.00
2,311.00
13,248.00
5,008.00
4,350
Total Current Assets
233,218.00
26,900.00
184,972.00
79,933.00
39,444
Net Property, Plant & Equipment
9,315.00
13,899.00
20,129.00
18,517.00
22,978
Total Investments and Advances
-
248,191.00
207,447.00
156,863.00
41,136
Long-Term Note Receivable
2,150.00
1,300.00
1,971.00
1,727.00
1,611
Intangible Assets
65,867.00
111,689.00
193,437.00
184,049.00
180,633
Other Assets
172.00
9,974.00
76,351.00
8,106.00
535
Total Assets
310,875.00
411,953.00
684,391.00
449,195.00
320,938
ST Debt & Current Portion LT Debt
34,502.00
-
-
-
Accounts Payable
4,136.00
6,447.00
6,039.00
3,164.00
Income Tax Payable
153.00
-
-
-
Other Current Liabilities
48,206.00
36,789.00
51,210.00
32,695.00
Total Current Liabilities
86,997.00
43,236.00
57,249.00
35,859.00
Long-Term Debt
-
-
191,040.00
195,458.00
Deferred Taxes
153.00
-
84.00
5,838.00
Other Liabilities
9,077.00
17,670.00
24,508.00
18,738.00
Total Liabilities
96,074.00
60,906.00
272,797.00
255,893.00
Common Equity (Total)
64,801.00
185,005.00
411,594.00
193,302.00
Total Shareholders' Equity
214,801.00
351,047.00
411,594.00
193,302.00
Total Equity
214,801.00
351,047.00
411,594.00
193,302.00
Liabilities & Shareholders' Equity
310,875.00
411,953.00
684,391.00
449,195.00
Preferred Stock (Carrying Value)
150,000.00
166,042.00
-
-

About NantHealth

View Profile
Address
9920 Jefferson Boulevard
Culver City California 90232
United States
Employees -
Website http://www.nanthealth.com
Updated 07/08/2019
NantHealth, Inc. ooperates as an evidence-based, personalized healthcare company, which provides treatment for critical diseases such as cancer. It is based on personalized healthcare approach that integrates novel diagnostics with large scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.